Fulgent Genetics ROA 2015-2025 | FLGT
Current and historical return on assets (ROA) values for Fulgent Genetics (FLGT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Fulgent Genetics ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $-0.04B | $1.22B | -3.64% |
| 2025-06-30 | $-0.05B | $1.20B | -4.28% |
| 2025-03-31 | $-0.04B | $1.21B | -3.43% |
| 2024-12-31 | $-0.04B | $1.22B | -3.50% |
| 2024-09-30 | $-0.17B | $1.23B | -13.38% |
| 2024-06-30 | $-0.16B | $1.23B | -12.90% |
| 2024-03-31 | $-0.17B | $1.23B | -12.75% |
| 2023-12-31 | $-0.17B | $1.24B | -12.54% |
| 2023-09-30 | $-0.06B | $1.36B | -4.60% |
| 2023-06-30 | $-0.05B | $1.36B | -3.48% |
| 2023-03-31 | $-0.03B | $1.38B | -1.78% |
| 2022-12-31 | $0.14B | $1.39B | 10.07% |
| 2022-09-30 | $0.27B | $1.41B | 19.38% |
| 2022-06-30 | $0.39B | $1.46B | 29.05% |
| 2022-03-31 | $0.46B | $1.47B | 36.88% |
| 2021-12-31 | $0.51B | $1.28B | 44.83% |
| 2021-09-30 | $0.57B | $1.21B | 57.66% |
| 2021-06-30 | $0.49B | $1.05B | 65.95% |
| 2021-03-31 | $0.42B | $1.00B | 81.68% |
| 2020-12-31 | $0.21B | $0.70B | 75.62% |
| 2020-09-30 | $0.05B | $0.25B | 36.85% |
| 2020-06-30 | $0.00B | $0.10B | 2.39% |
| 2020-03-31 | $0.00B | $0.09B | -1.36% |
| 2019-12-31 | $0.00B | $0.09B | -1.53% |
| 2019-09-30 | $0.00B | $0.06B | -5.29% |
| 2019-06-30 | $-0.01B | $0.06B | -9.05% |
| 2019-03-31 | $-0.01B | $0.06B | -10.86% |
| 2018-12-31 | $-0.01B | $0.05B | -10.91% |
| 2018-09-30 | $-0.01B | $0.06B | -10.76% |
| 2018-06-30 | $-0.01B | $0.06B | -10.57% |
| 2018-03-31 | $-0.01B | $0.06B | -8.70% |
| 2017-12-31 | $0.00B | $0.06B | -5.13% |
| 2017-09-30 | $0.00B | $0.06B | 0.00% |
| 2017-06-30 | $0.00B | $0.06B | 0.00% |
| 2017-03-31 | $-0.01B | $0.06B | -11.98% |
| 2016-12-31 | $-0.01B | $0.06B | -22.22% |
| 2016-06-30 | $-0.01B | $0.03B | -88.89% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.724B | $0.283B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $28.621B | 33.10 |
| Tempus AI (TEM) | United States | $9.242B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $4.646B | 0.00 |
| Doximity (DOCS) | United States | $4.621B | 20.02 |
| Hims & Hers Health (HIMS) | United States | $3.711B | 30.18 |
| Hinge Health (HNGE) | United States | $3.065B | 0.00 |
| Privia Health (PRVA) | United States | $2.754B | 172.23 |
| 10x Genomics (TXG) | United States | $2.293B | 0.00 |
| Heartflow (HTFL) | United States | $1.759B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.736B | 23.16 |
| Omnicell (OMCL) | United States | $1.638B | 45.62 |
| Azenta (AZTA) | United States | $1.318B | 53.00 |
| Enovis (ENOV) | United States | $1.245B | 6.54 |
| Clover Health Investments (CLOV) | United States | $1.044B | 0.00 |
| Schrodinger (SDGR) | United States | $0.840B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.768B | 0.00 |
| Phreesia (PHR) | United States | $0.720B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Standard BioTools (LAB) | United States | $0.431B | 0.00 |
| Claritev (CTEV) | United States | $0.380B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.338B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.320B | 0.00 |
| Evolent Health (EVH) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.307B | 0.00 |
| TruBridge (TBRG) | United States | $0.293B | 13.45 |
| Carlsmed (CARL) | United States | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.216B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.161B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.160B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.151B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.130B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 5.40 |
| American Well (AMWL) | United States | $0.088B | 0.00 |
| 111 (YI) | China | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.064B | 0.00 |
| Outset Medical (OM) | United States | $0.062B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Precipio (PRPO) | United States | $0.041B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.032B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.017B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| Movano (MOVE) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.005B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |